Literature DB >> 16524167

A short latency between radiation exposure from nuclear plants and cancer in young children.

Joseph J Mangano1.   

Abstract

Previous reports document a short latency of cancer onset in young children exposed to low doses of radioactivity. The standard mortality ratio (SMR) for cancer in children dying before age ten rose in the period 6-10 years after the Three Mile Island and Chernobyl accidents in populations most exposed to fallout. SMRs near most nuclear power plants were elevated 6-10 years after startup, particularly for leukemia. Cancer incidence in children under age ten living near New York and New Jersey nuclear plants increased 4-5 years after increases in average strontium-90 in baby teeth, and declined 4-5 years after Sr-90 averages dropped. The assumption that Sr-90 and childhood cancer are correlated is best supported for a supralinear dose-response, meaning the greatest per-dose risks are at the lowest doses. Findings document that the very young are especially susceptible to adverse effects of radiation exposure, even at relatively low doses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16524167     DOI: 10.2190/5GRE-KQ1B-UTM1-KHQ1

Source DB:  PubMed          Journal:  Int J Health Serv        ISSN: 0020-7314            Impact factor:   1.663


  4 in total

1.  Caring for the oldest old.

Authors:  Domhnall MacAuley; Zoe Slote Morris
Journal:  BMJ       Date:  2007-03-17

2.  Chronic eosinophilic leukemia with FIP1L1-PDGFRA transcripts after occupational and therapeutic exposure to radiation.

Authors:  Gueorgui Balatzenko; Nikolay Stoyanov; Elena Bekrieva; Margarita Guenova
Journal:  Hematol Rep       Date:  2011-10-11

Review 3.  Comparative Aspects of Osteosarcoma Pathogenesis in Humans and Dogs.

Authors:  Timothy M Fan; Chand Khanna
Journal:  Vet Sci       Date:  2015-08-17

4.  Emerging Environmental Justice Issues in Nuclear Power and Radioactive Contamination.

Authors:  Dean Kyne; Bob Bolin
Journal:  Int J Environ Res Public Health       Date:  2016-07-12       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.